bioRxivGeneticsPreprint
Cascade screening following a polygenic risk score test: what is the risk of a relative conditional on a high score of a proband?
Abstract
Polygenic risk scores (PRSs) for predicting disease risk have become increasingly accurate, leading to rising popularity of PRS tests. Consider an individual whose PRS test has placed him/her at the top q-quantile of genetic risk. Recently, Reid et al. (Circ Genom Precis Med. 2021;14:e003262) have investigated whether such a finding should motivate cascade screening in the probands siblings. Specifically, using data from the UK biobank, Reid et al. computed the empirical probability of a sibling of the proband to also have a PRS at the top q-quantile. In this short note, I use the liability threshold model to compute this probability analytically (for either a sibling of the proband or for a more distant relative), showing excellent agreement with the empirical results of Reid et al., including that this probability is disease-independent. Further, I compute the probability of the relative of the proband to be affected, as a function of the quantile threshold q, the proportion of variance explained by the score, and the disease prevalence.
- organism: human
- assay: GWAS summary statistics
- research focus: benchmarking
- approach: statistical model
- Citations
- 3
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Systematic comparison of family history and polygenic risk across 24 common diseases
Nina Mars, Joni Valdemar Lindbohm, … Samuli Ripatti·The American Journal of Human GeneticsPeer-reviewed·Nov 7, 2022
- Preventing premature deaths through polygenic risk scores
Melisa Chuong, Deborah J. Thompson, … Jack William O’Sullivan·Nature CommunicationsPeer-reviewed·Jan 21, 2026
- Within-Family Validation of Polygenic Risk Scores and Complex Trait Prediction
Louis Lello, Timothy G. Raben, Stephen Hsu·Scientific ReportsPeer-reviewed·Aug 6, 2020
- Utility of polygenic embryo screening for disease depends on the selection strategy
Todd Lencz, Daniel Backenroth, … Shai Carmi·eLifePeer-reviewed·Oct 11, 2021
- Performance of polygenic risk scores in screening, prediction, and risk stratification
Aroon Dinesh Hingorani, Jasmine Gratton, … NJ Wald·medRxiv·Feb 18, 2022
- A systematic framework for assessing the clinical impact of polygenic risk scores
Scott Kulm, Andrew R. Marderstein, … Olivier Elemento·medRxiv·Apr 6, 2020